Drug treatment strategies for insomnia in patients with post-traumatic stress disorder
| Autor: | Ali A. El Solh, Morohunfolu E. Akinnusi |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Sleep Wake Disorders
medicine.medical_specialty Stress Disorders Post-Traumatic Benzodiazepines 03 medical and health sciences Drug treatment 0302 clinical medicine Pharmacotherapy Sleep Initiation and Maintenance Disorders mental disorders medicine Insomnia Humans Hypnotics and Sedatives Pharmacology (medical) In patient Psychiatry Pharmacology Cognitive Behavioral Therapy business.industry Traumatic stress General Medicine Sleep in non-human animals 030220 oncology & carcinogenesis Quality of Life medicine.symptom Sleep business 030217 neurology & neurosurgery Antipsychotic Agents |
| Zdroj: | Expert Opinion on Pharmacotherapy. 20:691-699 |
| ISSN: | 1744-7666 1465-6566 |
| DOI: | 10.1080/14656566.2019.1574745 |
| Popis: | Insomnia is among the most reported sleep disturbances in patients with post-traumatic stress disorder (PTSD). The pervasiveness of this disorder among trauma-inflicted civilians and military personnel has been associated with reduced quality of life, impaired psychosocial functioning including cognitive impairments, negative mood swings, cardiovascular complications, and increased utilization of medical services.This review describes the current state of science with respect to the impact of the most dispensed pharmacological interventions for posttraumatic insomnia. At the present, there are no established treatment algorithms for PTSD-related insomnia. Pharmacotherapy offers an alternative treatment modality for patients with PTSD who fail or decline cognitive behavioral therapy (CBT). Selection of a hypnotic/sedative agent should be based on the patient's history, precipitating and perpetuating factors of insomnia, side effect profile, and potential medication-related interactions. Antipsychotics and benzodiazepines appear ineffective or are associated with significant harm in treating PTSD-related insomnia.In the absence of randomized controlled trials, prescription patterns have been guided by anecdotal reports and expert opinion. Due to the complexity and multifactorial etiology of insomnia in PTSD, clinical investigations should examine available pharmacologic agents in comparative trials or in combination with CBT or complementary therapies to assess both short-term and long-term sleep outcomes in this population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|